◼ Archived
Business
Genmab Stock Surges to Record High as Cancer Drug Slashes Risk of Death by 50%
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
2 trends tracked about this subject — the full history, oldest to newest below.
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Genmab releases new phase 2 data for its antibody-drug conjugate, prompting claims of superiority over rival treatments.